PMC:7534795 / 5671-6093
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T70564 | 28-33 | Body_part | denotes | organ | http://purl.org/sig/ont/fma/fma67498 |
| T71556 | 376-389 | Body_part | denotes | interleukin-1 | http://purl.org/sig/ont/fma/fma86583 |
| T41271 | 413-417 | Body_part | denotes | IL-1 | http://purl.org/sig/ont/fma/fma86583 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T16 | 28-33 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T53 | 65-71 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T85990 | 28-33 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organ |
| T15304 | 228-237 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
| T98618 | 376-389 | http://purl.obolibrary.org/obo/PR_000001091 | denotes | interleukin-1 |
| T66694 | 402-403 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T49 | 117-127 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T50 | 143-154 | Chemical | denotes | tofacitinib | http://purl.obolibrary.org/obo/CHEBI_71200 |
| T51 | 223-225 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T53 | 413-415 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4456 | 228-237 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T32 | 98-370 | Sentence | denotes | Janus kinase (JAK) inhibitors • Ruxolitinib, tofacitinib, baricitinib are proposed to be beneficial in controlling excessive IL-6 signaling through STAT-1 and STAT-3 pathways (Alijotas-Reig et al., 2020; Convertino et al., 2020; Richardson et al., 2020; Rizk et al., 2020) |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 33031856-32527304-84038805 | 92-96 | 32527304 | denotes | 2020 |
| 33031856-32527304-84038806 | 321-325 | 32527304 | denotes | 2020 |
| 33031856-32032529-84038807 | 346-350 | 32032529 | denotes | 2020 |
| 33031856-32696108-84038808 | 365-369 | 32696108 | denotes | 2020 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 162 | 223-227 | Gene | denotes | IL-6 | Gene:3569 |
| 163 | 246-252 | Gene | denotes | STAT-1 | Gene:6772 |
| 164 | 257-263 | Gene | denotes | STAT-3 | Gene:6774 |
| 176 | 376-389 | Gene | denotes | interleukin-1 | Gene:3552 |
| 192 | 57-103 | Disease | denotes | cardiac injury (Convertino et al., 2020) Janus | MESH:D006331 |